Although not directly, lower govt borrowings could lead to easier liquidity, which would be incrementally positive for banks and NBFCs’ NIMs. OMCs are likely to benefit from higher capital support. There is also a notable increase in the PLI scheme for the pharma sector, which could benefit select companies,” according to the brokerage.
Subscribe To Our Free Newsletter |